Jiangsu Nanfang Medical Co., Ltd. (603880.SS)
CNY 5.44
(-1.81%)
CNY 5.44
(-1.81%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 267.58 Million CNY | -7.44% |
| 2022 | 289.1 Million CNY | 33.34% |
| 2021 | 216.81 Million CNY | 83.16% |
| 2020 | 118.37 Million CNY | -0.17% |
| 2019 | 118.57 Million CNY | 17.74% |
| 2018 | 100.7 Million CNY | -4.52% |
| 2017 | 105.47 Million CNY | 34.06% |
| 2016 | 78.67 Million CNY | 30.05% |
| 2015 | 60.49 Million CNY | -13.13% |
| 2014 | 69.64 Million CNY | 13.83% |
| 2013 | 61.17 Million CNY | 14.91% |
| 2012 | 53.24 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 281.75 Million CNY | 4.36% |
| 2024 Q1 | 269.99 Million CNY | 0.9% |
| 2024 Q3 | 289.88 Million CNY | 2.89% |
| 2023 FY | 267.58 Million CNY | -7.44% |
| 2023 Q1 | 295.17 Million CNY | 2.1% |
| 2023 Q3 | 302.4 Million CNY | 6.87% |
| 2023 Q4 | 267.58 Million CNY | -11.51% |
| 2023 Q2 | 282.94 Million CNY | -4.14% |
| 2022 Q3 | 319.85 Million CNY | 9.43% |
| 2022 Q2 | 292.29 Million CNY | 17.34% |
| 2022 Q1 | 249.11 Million CNY | 14.9% |
| 2022 FY | 289.1 Million CNY | 33.34% |
| 2022 Q4 | 289.1 Million CNY | -9.61% |
| 2021 Q3 | 166.45 Million CNY | 10.54% |
| 2021 Q1 | 147.79 Million CNY | 24.85% |
| 2021 Q2 | 150.57 Million CNY | 1.89% |
| 2021 FY | 216.81 Million CNY | 83.16% |
| 2021 Q4 | 216.81 Million CNY | 30.26% |
| 2020 Q2 | 120.44 Million CNY | -9.49% |
| 2020 Q3 | 127.63 Million CNY | 5.97% |
| 2020 Q4 | 118.37 Million CNY | -7.25% |
| 2020 FY | 118.37 Million CNY | -0.17% |
| 2020 Q1 | 133.06 Million CNY | 12.22% |
| 2019 Q4 | 118.57 Million CNY | -6.55% |
| 2019 Q2 | 126.56 Million CNY | 14.72% |
| 2019 Q1 | 110.31 Million CNY | 9.55% |
| 2019 FY | 118.57 Million CNY | 17.74% |
| 2019 Q3 | 126.88 Million CNY | 0.25% |
| 2018 Q3 | 102.86 Million CNY | -4.99% |
| 2018 FY | 100.7 Million CNY | -4.52% |
| 2018 Q4 | 100.7 Million CNY | -2.1% |
| 2018 Q2 | 108.26 Million CNY | 9.42% |
| 2018 Q1 | 98.95 Million CNY | -6.18% |
| 2017 FY | 105.47 Million CNY | 34.06% |
| 2017 Q1 | - CNY | -100.0% |
| 2017 Q2 | - CNY | 0.0% |
| 2017 Q3 | 105 Million CNY | 0.0% |
| 2017 Q4 | 105.47 Million CNY | 0.44% |
| 2016 Q4 | 78.67 Million CNY | 0.0% |
| 2016 Q1 | - CNY | -100.0% |
| 2016 FY | 78.67 Million CNY | 30.05% |
| 2015 Q4 | 60.49 Million CNY | 0.0% |
| 2015 Q2 | 64.82 Million CNY | 0.0% |
| 2015 FY | 60.49 Million CNY | -13.13% |
| 2014 FY | 69.64 Million CNY | 13.83% |
| 2013 FY | 61.17 Million CNY | 14.91% |
| 2012 FY | 53.24 Million CNY | 0.0% |